Xenon Pharmaceuticals Inc (NASDAQ:XENE)
| 11.05 Delayed Data As of Sep 22 |  -0.15 / -1.34%Today’s Change | 7.00 Today|||52-Week Range 18.45 | -15.71% Year-to-Date |
Latest XENE News | Press Releases
No recent news for Xenon Pharmaceuticals Inc.
Today’s Trading
| Previous close | 11.20 |
| Today’s open | 11.14 |
| Day’s range | 10.92 - 11.27 |
| Volume | 3,581 |
| Average volume (3 months) | 161,145 |
| Market cap | $402.8M |
Data as of 4:37pm ET, 09/22/2020
Growth & Valuation
| Earnings growth (last year) | +5.19% |
| Earnings growth (this year) | +49.17% |
| Earnings growth (next 5 years) | +61.10% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 49.80 |
| Price/Book | 3.84 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MRNSMarinus Pharmaceutic... | -9.71 | -75.58% |
| BSTCBiospecifics Technol... | +0.36 | +0.67% |
| PBYIPuma Biotechnology I... | +0.27 | +2.68% |
| OVIDOvid Therapeutics In... | -0.02 | -0.32% |
Data as of 7:44pm ET, 09/22/2020
Financials
| Next reporting date | November 10, 2020 |
| EPS forecast (this quarter) | $0.01 |
| Annual revenue (last year) | $6.8M |
| Annual profit (last year) | -$41.6M |
| Net profit margin | -609.09% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Burnaby, British Columbia |
Forecasts
